Mentice AB (publ) (FRA:MN2)

Germany flag Germany · Delayed Price · Currency is EUR
1.160
-0.005 (-0.43%)
Last updated: Apr 24, 2026, 9:05 AM CET
Market Cap33.79M -32.3%
Revenue (ttm)26.30M -2.5%
Net Income-2.99M
EPS-0.11
Shares Outn/a
PE Ration/a
Forward PE153.22
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volume17
Open1.160
Previous Close1.165
Day's Range1.160 - 1.160
52-Week Range0.800 - 1.890
Betan/a
RSI43.36
Earnings DateApr 23, 2026

About Mentice AB

Mentice AB (publ), together with its subsidiaries, develops, sells, and markets solutions for training and decision support in the clinical area of interventional angiography in cardiology, neurology, vascular surgery, and radiology. It operates through the Mentice VIST, Physical Sim, and Ankyras segments. The company offers virtual simulation products, including VR simulator platforms; procedural learning models; patient simulator accessories and extensions for endovascular therapies; and Angiosuite integrations, such as the VIST virtual patie... [Read more]

Industry Prepackaged Software
Founded 1998
Employees 124
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol MN2

Financial Performance

In 2025, Mentice AB's revenue was 284.59 million, a decrease of -2.48% compared to the previous year's 291.81 million. Losses were -32.33 million, 75.5% more than in 2024.

Financial numbers in SEK Financial Statements